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The effect of potassium depolarization on dopamine D 1 receptor activity in bovine retina was investigated. Preincubation of bovine retinas 
in buffer containing high KC1 (56 mM) as compared to a low KC1 control buffer resulted in a significant decrease in dopamine-stimulated 
adenylate cyclase activity with no change in basal or GTP-stimulated adenylate cyclase activity. The apparent Vr~ax for dopamine was decreased 
from 102 + 15 pmol/min/mg protein in retinas preincubated in high KC1 to 71 + 11 pmol/min/mg protein in control retinas (n = 5). The apparent 
K a for dopamine stimulation of the enzyme did not change. The potassium-induced desensitization could be blocked by preincubation with 
the dopamine antagonist cis-flupenthixol suggesting that the desensitization was caused by the release of dopamine. The rapid desensitization 
was not accompanied by a change in D1 receptor density as assessed by binding of [3H]SCH23390 nor in agonist binding as assessed by 
competition of the selective D 1 agonist, SKF38393, for [3H]SCH23390 binding. The potassium-induced desensitization was mimicked by 
preincubation of retinas in control medium containing isobutytmethylxanthine or dibutyryl cyclic AMP. Incubation of retinas in 56 mM KCI 
also led to a decrease in activation of adenylate cyclase by vasoactive intestinal polypeptide. These results strongly suggest that potassium 
depolarization leads to a very rapid heterologous desensitization of adenylate cyclase in bovine retinas. 
INTRODUCTION 
Dopamine  (DA)  has been well established as a 
neuro t ransmi t te r  in the ret ina and this tissue has been 
extensively used to investigate the D A  neurot ransmit ter  
system. DA-con ta in ing  neurons are located among the 
amacrine  cells in the inner  nuclear  layer of the ret ina 7. 
D A  D1 receptors  present  in the inner ret ina stimulate 
adenyla te  cyclase activity 4"26. Electrophysiological  studies 
have shown that  D A  affects the receptive field proper t ies  
of ganglion cells in mammal ian  ret ina 1'3°'32. In rabbit  
ret ina,  D 1 receptor  antagonists  were found to affect the 
spontaneous  activity of on- and off-center ganglion cells 
and to abolish the antagonist  surround H'a2. D 1 receptors  
have also been shown to media te  acetylcholine release in 
mammal ian  ret ina 9. In fish retinas,  D 1 receptor  activation 
has been shown to uncouple electrical synapses between 
horizontal  cells 31. 
D A  has been shown to be re leased from its neurons in 
ret ina in response to light 2"~5. D A  released in response to 
light could act at postsynaptic  Dt  receptors  and subse- 
quently alter the responsiveness of that receptor.  In 
previous studies,  we found a rapidly-occurring desensiti- 
zation of DA-s t imula ted  adenylate  cyclase activity in 
membrane  fractions of bovine ret ina that occurred after 
preincubat ion of the retinas under  light as compared  to 
dark condit ions 6. The desensi t izat ion was manifested as 
a significant decrease in the apparent  Vma x for D A ,  with 
no change in the apparen t  K a. Preincubat ion of the 
retinas with D A  produced  a desensi t izat ion of the 
DA-s t imula ted  adenyla te  cyclase activity that  resembled  
that of light, support ing the conclusion that release of 
D A  media ted  the l ight- induced desensi t izat ion of the 
enzyme activity. 
One caveat to those exper iments  is that rhodopsin 
could not  be continuously regenera ted  in the isolated 
bovine ret ina under  the pre incubat ion conditions.  In 
order  to further investigate the molecular  mechanism of 
the desensit ization of the D 1 receptor  in bovine ret ina,  a 
depolar izing concentra t ion of potassium was used to 
release D A .  Incubat ion of retinas with depolar izing 
concentrat ions of potassium has been shown to release 
D A  and increase c A M P  content  in mammal ian ,  amphib-  
ian and fish retinas 2'5'25. The increase in cAMP can be 
blocked by D A  receptor  antagonists  5'2s, further  demon- 
strating that  K + depolar iza t ion  releases D A .  
In this report ,  we demons t ra te  a rapid desensit ization 
of DA-sensi t ive  adenyla te  cyclase in mammal ian  retinas 
in response to potass ium-induced depolar izat ion.  We 
then examine whether  the desensi t izat ion is due to a 
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change  at the  leve l  of  the  r ecep to r  o r  an a l te ra t ion  in the 
coup l ing  of  the  r e c e p t o r  to adeny la t e  cyclase.  O u r  s tudies 
ind ica te  tha t  po ta s s ium depo la r i za t ion  leads  to a desen-  
s i t izat ion o f  adeny la t e  cyclase act ivi ty  that  is no t  specif ic  
for  D A .  T h e  resul ts  a re  compa t ib l e  with d e v e l o p m e n t  of  
h e t e r o l o g o u s  desens i t i za t ion  which is due  to an uncou-  
pl ing o f  r ecep to r s  f rom the  s t imula to ry  G T P - b i n d i n g  
p ro te in ,  Gs  8'27. 
MATERIALS AND METHODS 
Tissue treatment 
Bovine eyes were obtained from a slaughterhouse shortly after the 
animals' death, maintained in the dark and transported on ice. 
Retinas were dissected from the eyes in a dark room under a dim 
red light (Kodak Adjustable Safelight Lamp Model B). The eye was 
hemisected, and the back of the eyeball was inverted, releasing the 
vitreous humor. The retina was gently removed from the underlying 
choroid and sclera using forceps and placed in physiological buffer. 
Treatment with high potassium 
The physiological buffer used contained 30 m/M HEPES buffer, 
pH 7.4, 1.7 mM CaC12, 2.9 mM NaHCO 3, 1.0 mM MgCI z, 1 mg/ml 
glucose, KCI and NaCI. The buffer for high potassium treatment 
contained 56 mM KCI and 91.6 mM NaCI, while buffer for control 
retinas contained 5.6 mM KCI and 142 mM NaCI. Incubations were 
conducted for 15 min at 37 °C in the dark room immediately after 
dissection of retinas. Retinas were placed in previously oxygenated 
control or treatment buffer in airtight plastic tubes in a ratio of 0.75 
ml buffer per retina. The reaction was stopped by diluting the tissue 
with 4 vols. of the buffer used for adenylate cyclase or binding 
assays. The tissue was centrifuged and,' washed 3 times with the 
appropriate buffer. Treatment groups were paired within a given 
experiment to minimize errors associated with interassay variability. 
Adenylate cyclase assays 
Membrane fractions were prepared by homogenizing the tissue in 
l0 vols. of 20 mM HEPES buffer, pH 7.5, containing 1.2 mM 
EGTA and 5 mM MgSO4 in a glass teflon homogenizer. The 
homogenate was centrifuged at 27,000 g for 20 min and washed 
twice. The resulting pellet was resuspended in the HEPES buffer. 
The assay, in a volume of 200/d, contained 20 mM HEPES, pH 7.5, 
5 mM MgC12, 2 mM cAMP, 4 mM phosphenolpyruvate (PEP), 20 
#g pyruvate kinase, 0.12 mM isobutylmethylxanthine (IBMX), 0.5 
mM [a-32p]ATP (1/~Ci/assay), and 25/A of particulate membrane 
fraction to give a protein concentration of 0.1 mg/ml, with or 
without the addition of 1 /~M GTP, DA or vasoactive intestinal 
polypeptide (VIP). DA- or VIP-stimulated adenylate cyclase activ- 
ities were calculated as the pmol of cAMP/min/mg protein produced 
above that activity in the presence of GTP alone. Assays were 
incubated for 8 min at 37 °C and the reaction was stopped by heating 
for 1 min at 95 °C, followed by addition of 200/~1 of a solution 
containing 20 mM ATP and 0.7 mM [3H]cAMP. The particulate 
material was centrifuged and the 32p-labeled cAMP in the super- 
natant fraction was separated from [32p]ATP over a Biorad AG-50 
resin column followed by precipitation with Ba(OH)2 and Z n S O  4 
according to Krishna et a1.16. Recovery of cAMP was measured 
using the [3H]cAMP and was usually 80-90%. 
[3H]SCH 23390 binding assay 
Membrane fractions were prepared as described for adenylate 
cyclase assays with two exceptions. Retinas were homogenized in 20 
mM HEPES buffer, pH 7.8, containing 1.2 mM EGTA, 5 mM 
MgSO 4 and 0.32 M sucrose with a Brinkman polytron for 10 s at 
setting 6 prior to centrifugation. The assay, in a volume of 1 ml, 
contained [3H]SCH 23390, unlabeled competing drug or buffer, 
0.1% tartaric acid and 800 /~1 of membranes to give a protein 
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concentration of 0.1 mg/mi. Samples were incubated for 90 min at 
25 °C. Non-specific binding was determined in the presence of 10 
/~M c/s-flupenthixol. The binding reaction was terminated by rapid 
filtration over Whatman GF/C filters and immediate rinsing 4 times 
with 4 ml of ice-cold 50 mM Tris HCI buffer, pH 7.7. The filters 
were allowed to air dry for 30 min, placed in xylene-based Aqueous 
Counting Scintillant (ACS) and shaken for 30 min. Radioactivity 
was determined by liquid scintillation spectrophotometry. 
Protein measurement 
Protein was determined by the method of Lowry et al. 17. 
Data analysis 
Statistical analysis was performed using paired Student t-test. K d 
and Bma x values for [3H]SCH23390 binding were determined from 
Scatchard analysis. The data fit to a single site and linear regression 
was used to calculate the actual values. A possible difference in K d 
or  Bma x values for [3H]SCH23390 binding for control and KCI- 
treated retinas was also assessed by non-linear regression analysis 
using Graph PAD (ISI, Philadelphia, PA). The data were first 
analyzed simultaneously with the K 0 and Bm~ x values both con- 
strained to be estimated as a common value between treatment 
groups (pooled fit). The data were then analyzed such that both 
parameters could vary between control and KCI treatment groups 
(separate fit). The improvement in fit produced by relaxing the 
constraints was assessed using the variance ratio (F statistic) derived 
from the residual variance (the ratio of the sum of squares of the 
residuals divided by the degrees of freedom) as described by 
Motulsky and Ransnas 19. The F ratio was calculated using the 
equation F = [(SSpool- SS~ep)/dfpool - -  dfs~p)]/(SSs~dfsep) where 
SSpoo~ = sum of squares of the combined fit, SSse p = sum of squares 
of the separate fits, dfpoo~ = the degrees of freedom of the combined 
fit and df~p = degrees of freedom of the separate fit. The curves for 
competition of SKF38393 for [3H]SCH23390 binding were fit to a 
two site model using Graph PAD. The curves were analyzed with 
the K~ values for the two sites estimated to be a common value and 
with the constraints relaxed. The improvement in fit produced by 
relaxing the constraints was assessed as described above. 
Materials 
[a-32p]ATP (30 Ci/mmol) and [3H]SCH 23390 (76 Ci/mmol) were 
obtained from Amersham Searle, Arlington Heights, IL. ATP, 
cAMP, PEP and BSA were purchased from Sigma Chemical Co., 
St. Louis, MO. GTP and pyruvate kinase were from Boehringer- 
Mannheim, Indianapolis, IN. C/s-flupenthixol was graciously do- 
nated by H. Lunbeck, A/S, Copenhagen, Denmark. SKF38393 was 
generously donated by Smith Kline and French Pharmaceuticals, 
Philadelphia, PA. 
RESULTS 
Fol lowing  incuba t ion  with 56 m M  KCI,  the re  was a 
s ignif icant  dec rease  in s t imula t ion  o f  adeny la t e  cyclase by 
D A  in ret inal  m e m b r a n e s  as c o m p a r e d  to m e m b r a n e s  
f rom ret inas  p r e incuba t ed  in low po ta s s ium (Fig. 1). 
Kine t ic  analysis of  e n z y m e  act ivi ty  using a H a n e s  plot  
d e m o n s t r a t e d  that  the re  was a s ignif icant  d i f fe rence  in 
the  appa ren t  Vma x for  D A  in re t inas  t r ea t ed  with  high 
KCI,  as c o m p a r e d  to the  low KC! cont ro l .  T h e  appa ren t  
Vma x of  the reac t ion  dec reased  f r o m  102 + 15 pmol /  
min /mg pro te in  for  con t ro l  re t inas  to 71 ___ 11 pmol /  
m in /mg  pro te in  for  high KCI - t r ea t ed  re t inas  (n = 5, P < 
0.05, two- ta i led  pa i red  t). T h e  appa ren t  Ka va lue  o f  the  
e n z y m e  was no t  s ignif icant ly d i f fe ren t  b e t w e e n  the  two 
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Fig. 1. DA-stimulated adenylate cyclase activity in bovine retina 
after preincubation with high KCI or under control conditions. 
Activation of adenylate cyclase by DA was measured in membranes 
prepared from retinas incubated in physiological buffer containing 
low or with high KCI as described in Methods. DA-stimulated 
activity was calculated as described in Methods. Adenylate cyclase 
activities in the presence of GTP are given in the text. Each point 
represents the average + SE of 5 separate determinations per- 
formed in triplicate. *P < 0.05 for treatment as compared to 
control, paired t-test. 
control and high KCl-treated retinas, respectively. The 
apparent K a values were averaged as the logarithm base 
10 therefore the standard error (numbers in parentheses) 
is expressed as a range. 
The basal adenylate cyclase activities in the control and 
treatment groups were not significantly different, being 
59 + 11 vs 47 + 4 pmol/min/mg protein, respectively (n 
= 5). Activities measured in the presence of 1/~M GTP 
in the control and treatment groups were also not 
significantly different (67 + 11 vs 49 + 4 pmol/min/mg 
protein, respectively (n = 5). The control values appear 
somewhat higher than treatment values due to one high 
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Fig. 2. Effect of 500 nM cis-flupenthixol on potassium-induced 
decrease in DA-stimulated adenylate cyclase activity in bovine 
retina. Retinas were preincubated under control (cont) conditions 
or in the presence of 56 mM KCI (K) in the absence or presence 
(cont-cf, K-cf) of 500 nM cis-flupenthixol as described in Methods. 
The results are shown as the DA-stimulated adenylate cyclase 
activity for 10/~M (solid bars) and 100/tM (striped bars) DA in pmol 
of cAMP/min/mg protein. Results are the average of 4 experiments 
_+ S.E. each performed in triplicate. Adenylate cyclase activities in 
the presence of 1/tM GTP in pmol/min/mg prot. for cont, cont-cf, 
K and K-cf groups were: 61 + 6, 57 + 8, 55 + 8 and 39 + 9, 
respectively. *P < 0.05 as compared to cont and K-cf conditions, 
paired t-test. **P < 0.05 as compared to cont, cont-cf, and K-cf 
conditions, paired t-test. 
control value that skewed the average. 
To further determine whether the desensitization pro- 
duced by depolarization was due to a release of DA, the 
ability of a DA receptor antagonist to block the desen- 
sitization was examined. Retinas were preincubated 
under low (control) and high KC1 conditions with and 
without 500 nM cis-flupenthixol. The inclusion of 500 nM 
cis-flupenthixol in the preincubation blocked the KCI- 
induced decrease in stimulation of adenylate cyclase by 
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Fig. 3. Binding of [3H]SCH23390 to bovine retinal membranes after preincubation under control conditions or with high KCI. Binding of 
[3H]SCH23390 to retinal membranes was measured as described in Methods. A: saturation curve for [3H]SCH23390 binding. B: Scatchard 
analysis of data in A. Each point represents the mean + S.E. for 5 separate experiments. Kinetic constants are given in text. 
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itself had no effect on D A  activation under control 
conditions. 
The possibility that the desensitization was due to a 
change in number  or  affinity of D 1 receptors was 
examined by measuring the binding of a labeled antag- 
onist to D1 receptors on the membranes after preincu- 
bation in high KC1 or control conditions. The level of  D~ 
receptors in retinas was measured initially with the 
specific D x antagonist, [3H]SCH23390. Saturation curves 
representing specific binding of  [3H]SCH23390 to retinal 
membranes  after preincubation in high KCI or control 
conditions are shown in Fig. 3. The data in Fig. 3A 
demonstrate  that there was no significant difference in 
the affinity or density of D1 receptors present in retinas 
preincubated under control conditions or  with high KC1. 
Scatchard analysis (Fig. 3B) of  the saturation experi- 
ments produced Bma x values of  415 + 38 fmol/mg protein 
and 371 + 43 fmol/mg protein for control and high KCI 
treatment groups, respectively (n = 5). The K d values for 
[3H]SCH23390 were 0.32 (0.298-0.35) nM and 0.33 
(0.27-0.40) nM for control and treatment groups, re- 
spectively. The K d values were averaged as the logarithm 
base 10, therefore the standard errors are given as a 
range. The results were also analyzed using non-linear 
regression analysis with the program Graph PAD.  The 
combined saturation curves from 5 control and 5 KCI- 
treated retinas were fit simultaneously with no constraints 
placed on the analyses. The average Bma x values for 
control and treatment retinas calculated by this analysis 
were, in fmol/mg protein, 435 + 35 and 387 + 47, 
respectively. It was found that the fit by non-linear least 
square analysis fitted with combined and separate F-test 
showed no improvement  with sum of squares residuals (F 
= 1.09, P > 0.05). Therefore neither the Bma x nor K d 
values for the two groups were significantly different. 
Al though no difference in receptor density was de- 
tected by measuring antagonist binding, it is possible that 
there could be a selective alteration of D 1 agonist binding 
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Fig. 4. Competition for [3H]SCH23390 binding sites by SKF38393 
following preincubation of bovine retinas with low or high KC1. 
Non-specific binding was determined with 10 pM c/s-flupenthixol. 
The concentration of [3H]SCH23390 was 0.15 nM. Each point 
represents the average of one to 3 separate experiments conducted 
in triplicate. 
sites, which would be detected by measuring agonist 
competition with labeled [3H]SCH23390. Competit ion 
for [3H]SCH 23390 binding by the D 1 receptor agonist 
SKF38393 was measured following treatment with high 
KC1 (Fig. 4). The curves were fit to a two site analysis 
using Graph PAD.  In 3 separate experiments, no 
difference was found between control and treatment 
groups in the ability of  the selective D 1 agonist SKF38393 
to compete for [3H]SCH23390 binding sites. The K i 
values for SKF38393 competit ion for the combined 
control experiments were 43 nM and 280 nM for the high 
and low affinity sites, respectively, and 40% of the sites 
were of high affinity.The K i values for SKF38393 com- 
petition for the combined KCI treatment experiments 
were 2 nM and 180 nM for the high and low affinity sites, 
respectively, and 19% of the sites were of high affinity. 
Calculation of the variance ratio (F  statistic) as described 
by Motulsky and Ransnas 19 demonstrated that there was 
TABLE I 
Effect of preincubation with 1BMX or dbcAMP on activation of  adenylate cyclase by IO0 pM DA in bovine retina 
Adenylate cyclase activity is expressed as pmol of cAMP/min/mg protein produced by 100/~M DA above that activity in the presence of 1/~M 
GTP. Adenylate cyclase activities in the presence of GTP, in pmol/min/mg protein fopr Expt. 1 control, KCI, IBMX treatment and IBMX + KC1 
are: 31 + 2, 34 + 5, 48 + 8 and 31 + 5, respectively. Adenylate cyclase activities in the presence of GTP, in pmol/min/mg protein, for Expt. 2 are: 
45 + 5, 37 + 6 and 45 + 5, respectively, n.d. = not determined. 
DA -stimulated adenylate cyclase activity (pmol/min/mg prot.) 
n Control 56 mM KCI Treatment Treatment + KCI 
Expt. 1:2 mM IBMX 4 68 + 8 
Expt. 2: I mM dbcAMP 3 94 + 3 
*P -< 0.05 with respect to corresponding control, paired t-test. 
**P ~ 0.05 with respect to Expt. 2 control, unpaired t-test. 
28 + 8* 32 + 4* 41 + 7** 
75 + 5** 80 + 3* n.d. 
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TABLE II 
Stimulation of adenylate cyclase activity by V1P following incubation 
of bovine retinas with 56 mM KCI 
VIP-stimulated adenylate cyclase activity is expressed as the pmol of 
cAMP produced/min/mg protein above that activity in the presence 
of 1 ~tM GTE Adenylate cyclase activities in the presence of 1 ~M 
GTP for control and 56 mM KCI preincubations are: 55 and 42 
pmol/min/mg protein, respectively. Results are the average of 2 
experiments, performed in triplicate, that differed less than 10%, 
VIP concentration VIP-stimulated adenylate cyclase activity 
(raM) (pmol/min/mg prot. ) 
Control 56 mM KCl 
l 29 15 
10 34 24 
100 75 31 
no improvement in fit produced by relaxing the con- 
straints between the control and treatment values. There- 
fore there was no significant difference in agonist binding 
tO [3H] SCH23390 binding sites between the control and 
KC1 treatment groups (F = 0.68, p >/ 0.05). 
The lack of change in D 1 receptor binding suggested 
that potassium depolarization could have produced a 
heterologous desensitization which is partially mediated 
by cAMP 27. To examine this possibility, retinas were 
preincubated with IBMX, a phosphodiesterase inhibitor, 
and dibutyryl cAMP. As shown in Table I, there was a 
significant decrease in pmol of cAMP produced/min/mg 
protein in retinas preincubated under control conditions 
with 2 mM IBMX as compared to retinas preincubated 
solely under control conditions. Preincubation of retinas 
with KCI+IBMX produced no greater desensitization 
than that induced by either agent alone. Similarly, 
preincubation of retinas in the presence of 1 mM 
dibutyryl cAMP also produced a desensitization of 
DA-stimulated adenylate cyclase activity. Neither IBMX 
nor dibutyryl cAMP altered the basal or GTP-stimulated 
adenylate cyclase activity in any group. 
We then determined whether the desensitization pro- 
duced by potassium depolarization was specific for the D~ 
DA receptor. Following incubation of retinas with con- 
trol or high potassium buffer, the stimulation of adenyl- 
ate cyclase activity by VIP was measured. As shown in 
Table II, the stimulation of adenylate cyclase activity was 
decreased in retinas preincubated with high KCI at each 
concentration of VIP measured. 
DISCUSSION 
We have found that potassium depolarization elicited 
a rapid desensitization of D~ receptor stimulation of 
adenylate cyclase activity in bovine retinas. It is likely 
that the DA receptor desensitization was mediated by a 
release of DA from retinal neurons. It has been shown 
that incubation of retinas, including calf retina, with 
potassium increases cAMP content in the retina and this 
can be blocked with DA receptor antagonists 5"2~. In this 
study it was found that the potassium-induced desensiti- 
zation of the DA-stimulated adenylate cyclase activity 
could be blocked with cis-f lupenthixol ,  a DA receptor 
antagonist. 
The desensitization was manifested by a decrease in 
apparent Vma × for DA-stimulated adenylate cyclase ac- 
tivity with no change in affinity for DA. There was no 
measurable change in DA receptor density or agonist 
affinity as determined by binding of the antagonist 
[3H]SCH23390 or by agonist competition for antagonist 
binding. The simplest explanation for the results is that 
potassium releases DA, which activates postsynaptic Dl 
receptor and brings about a desensitization of that 
receptor. Another possible explanation for the results is 
that KC1 would induce an increase in D 2 receptor activity, 
which inhibits adenylate cyclase 29, causing a resultant 
decrease in Dl-mediated stimulation. This would require 
that D~ and D 2 receptors be located on the same 
postsynaptic membrane and be functionally coupled. 
Using autoradiography, Brann and Young 3 found that D 2 
receptor-specific ligands densely labeled rods in bovine 
retina but there was very little specific labeling in the 
inner nuclear or inner plexiform layers. D e receptors that 
are present in the inner layers of the bovine retina have 
been shown to modulate release of DA from cells 25. 
Pachter and Lam 21 found that neither D 2 agonists nor 
antagonists altered DA-stimulated adenylate cyclase ac- 
tivity in rabbit retinal homogenates. Qu e t  al. 24, however, 
recently reported that inhibition of adenylate cyclase by 
DA and D 2 agonists could be measured in intact rat 
retina after preincubation with SCH23390. These results 
suggest that D 1 and D 2 receptors could be functionally 
coupled on the rat retinal membrane. If this is true in 
bovine retina, the KCl-mediated release of DA, while 
initially activating D 2 receptors, would probably result in 
a desensitization of D 2 receptors thereby decreasing the 
D 2 activity upon subsequent measurement in an assay. 
Further, preliminary experiments using SKF38393, a 
selective D 1 agonist, instead of DA also demonstrated 
the desensitization. The experiments demonstrating the 
blockade of the KCl-induced desensitization with c/s- 
flupenthixol do not answer this question since cis- 
flupenthixol has nearly equal affinity for Dl and D 2 
receptors. The studies of VIP activation and IBMX- and 
dbcAMP-induced desensitization coupled with the tack of 
change of D~ receptor binding, however, strongly suggest 
that the desensitization induced by potassium is hetero- 
logous in nature. In heterologous desensitization, no 
change is found in receptor binding characteristics, but 
there is a decrease in activation of adenylate cyclase by 
the desensitizing hormone/neurotransmitter and other 
neurotransmitters that are coupled to the common 
adenylate cyclase catalytic subunit 8'27. There may be a 
slight decrease in activity of agents that act at Gs such as 
GTP. In most of our experiments, stimulation by GTP 
was unaltered by KCI treatment, although in some assays 
(see legend to Fig. 2) there were decreases in GTP 
stimulation. In this study, we found a decrease in 
stimulation of adenylate cyclase by both DA and VIP in 
retinas after preincubation in high potassium. There is 
some evidence that D A  and VIP receptors can exist on 
the same cells in retina. Pachter and Lam 21 have found 
that both D A  and VIP stimulate adenylate cyclase in 
homogenates of rabbit retina in a non-additive manner. 
VIP activation of adenylate cyclase has also been dem- 
onstrated in isolated horizontal cells of fish retina that 
contain DA receptors 33. The potassium-induced desen- 
sitization could be mimicked by IBMX and dibutyryl 
cAMP suggesting that a cAMP-dependent phosphoryla- 
tion partially mediates the desensitization as has been 
demonstrated for heterologous desensitization 27 of the 
fl-adrenergic receptor. 
The preincubation of retinas with high concentrations 
of potassium could mimic the effect of light on the 
retinas. Light has been shown to release DA from its 
neurons in retinas 2'~5. It has been demonstrated that the 
light-stimulated release of DA in rabbit retina is similar 
to that evoked by membrane depolarization by high 
potassium concentrations or electric current 2'2°. Light has 
also been shown to regulate D A D  1 receptor activity in 
mammalian retinas. We have previously shown that 
preincubation of bovine retinas for 20 min under light 
conditions produced a desensitization of DA-stimulated 
adenylate cyclase as compared to those preincubated 
under dark conditions 6. The light-induced desensitization 
could be mimicked by preincubation with DA. Porceddu 
et al. 22 found a greater activation of adenylate cyclase 
activity by DA in retinas from rats subjected to 4 h of 
dark adaptation as compared to light-adapted animals. In 
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